gallstones/aptaukošanās

Saite tiek saglabāta starpliktuvē

Izvēlieties kārtošanas veidu

12 rezultātiem

Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

The contents of the text file named SYPA-003_C04US_SeqList_ST25.txt, which was created on Jun. 17, 2015 and is 107 KB in size, are hereby incorporated by reference in their entirety. FIELD OF THE INVENTION The present invention relates to the therapeutic use of guanylate cyclase C (GC-C) agonists as

Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

FIELD OF THE INVENTION The present invention relates to the therapeutic use of guanylate cyclase C (GC-C) agonists as for reducing absorption of fat, triglycerides, bile acids and cholesterol. The agonists may be used either alone or in combination with inhibitors of cholesterol biosynthesis in the

Treatment of gallstones

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

THIS INVENTION RELATES TO A METHOD OF TREATING GALLSTONES. According to the present invention there is provided a method of treating gallstones, in which a therapeutically effective amount of a compound of formula I ##STR2## including enantiomers and pharmaceutically acceptable salts thereof, in

Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

TECHNICAL FIELD The present invention relates to novel phenylaminoalkyl-carboxylic acid derivatives and pharmaceutically acceptable salts thereof which are useful as medicaments. BACKGROUND ART It is known that three subtypes of sympathomimetic .beta.-adrenoceptors, which have been classified as

Indazole compounds

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

TECHNICAL FIELD The present invention relates to indazole compounds having a .beta.3 adrenergic receptor agonist activity, a pharmaceutical composition containing the same, and uses of the compounds and the composition. BACKGROUND ART Noradrenaline and adrenaline are known to exhibit a variety of

Use of ivermectin and derivatives thereof

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a National Stage filing under 35 U.S.C. .sctn. 371 of International Patent Application No. PCT/CN2013/077796, filed on Jun. 24, 2013, entitled "Use of Ivermectin and Derivatives Thereof", which claims the benefit of and priority to Chinese

2-methylpropionic acid derivatives and pharmaceutical compositions comprising the same

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

TECHNICAL FIELD The present invention relates to novel 2-methylpropionic acid derivatives and pharmaceutically acceptable salts thereof which are useful as medicaments. BACKGROUND ART It is known that three subtypes of sympathetic .beta.-adrenoceptors, which have been classified as .beta..sub.1,

2-Methylpropionic acid derivatives and medicinal compositions containing the same

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

Phenoxyacetic acid derivatives and medicinal compositions containing the same

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

TECHNICAL FIELD The present invention relates to novel phenoxyacetic acid derivatives and pharmaceutically acceptable salts thereof which are useful as medicaments. BACKGROUND ART It is known that three subtypes of sympathetic .beta.-adrenoceptor, which have been classified as .beta..sub.1,

Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

DESCRIPTION This invention relates to the use of nucleic acid sequences of the MAP kinase-interacting kinase (Mnk) gene family and amino acid sequences encoded thereby, and to the use of these sequences or effectors of Mnk nucleic acids or polypeptides, particularly Mnk kinase inhibitors and

Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to PCT Patent Application No. PCT/EP02/03540 filed Mar. 28, 2002 and European Patent Applications No. EP01 108 315.1 filed Apr. 2, 2001 and EP01 113 419.4 filed Jun. 1, 2001. DESCRIPTION This invention relates to the use of

Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji

Ielogoties Reģistrēties

DESCRIPTION This invention relates to the use of nucleic acid and amino acid sequences of protein disulfide isomerase and ABC transporter homologous proteins, and to the use of these sequences in the diagnosis, study, prevention, and treatment of diseases and disorders related to body-weight

Pievienojieties mūsu
facebook lapai

Herbal & Natural Medicine

Vispilnīgākā ārstniecības augu datu bāze, kuru atbalsta zinātne

Darbojas 55 valodās
Zāļu ārstniecības līdzekļi, kurus atbalsta zinātne
Garšaugu atpazīšana pēc attēla
Interaktīva GPS karte - atzīmējiet garšaugus atrašanās vietā (drīzumā)
Lasiet zinātniskās publikācijas, kas saistītas ar jūsu meklēšanu
Meklēt ārstniecības augus pēc to iedarbības
Organizējiet savas intereses un sekojiet līdzi jaunumiem, klīniskajiem izmēģinājumiem un patentiem

Ierakstiet simptomu vai slimību un izlasiet par garšaugiem, kas varētu palīdzēt, ierakstiet zāli un redziet slimības un simptomus, pret kuriem tā tiek lietota.
* Visa informācija ir balstīta uz publicētiem zinātniskiem pētījumiem